SEC filing · 8-K

Kestra Medical Technologies, Ltd.: Quarterly results

Kestra Medical Technologies reported a 60% revenue increase for the first quarter of fiscal 2027 and raised its full-year revenue guidance.

Filed September 14, 2026

Mixed for the company

What happened

Total revenue rose to $31.0 million, representing an increase of 60% compared to the prior year period.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov Press release (EX-99.1) All documents of this filing

Back to Kestra Medical Technologies, Ltd.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.